NCT02531204View on ClinicalTrials.gov

A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
HealthyUrine Phosphorus Excretion
Interventions
DRUG

ASP1585

oral

Trial Locations (1)

Unknown

Kagoshima

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY